Abstract
Germinating seeds contain several groups of proteases that have been implicated in seed germination. The major function of the proteases is to help in degradation and mobilization of storage proteins. The germinating seeds rich in active enzymes, especially proteases, have been used in therapeutic and as antiaging diet components.
This study aimed to study the role of cysteine protease purified from sprouted Lablab purpureus seed radicle extract (LPRE) in hemostasis and platelet aggregation. The cysteine protease has been purified by two-step purification using Sephadex G-75 and DEAE Sephadex A-50 column chromatography. The protease is named as “Purpurease.” The SDS-PAGE, reversed phase HPLC, and MALDI-TOF mass spectrometry confirmed the homogeneity and purity of the purified protease. The molecular weight of the “Purpurease” was found to be 47.2 kDa. The protease was assayed using fat-free casein and gelatin as substrate. Among protease inhibitors EDTA, 1,10-phenanthroline, aprotinin, E-64, and pepstatin-A, E-64 inactivated the enzyme irreversibly indicating the cysteine type of protease. The protease hydrolyzed fibrinogen in a dose-dependent manner. The protease was evaluated for effect on blood coagulation both in vitro and in vivo studies. The protease showed strong anticoagulant activity in studied methods of prothrombin time (PT), activated partial thromboplastin time (APTT), and recalcification time (RT). In an in vivo study using mouse model, the protease exhibited anticoagulant activity in tail bleeding assay increasing the bleeding time from 140 ± 5 sec to 650 ± 20 sec. The protease further evaluated for its effect on platelet aggregation. The protease inhibited the platelet aggregation significantly when collagen and ADP used as agonists. The protease inhibited platelet aggregation to an extent of 82% and 68% with collagen and ADP-induced aggregation, respectively.
Thus a cysteine protease has been purified and evaluated for its effect on coagulation and platelet aggregation. The protease can be studied further for its therapeutic potential.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP (2019) Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation 139(10):e56–e528
World Health Organization (2017) Cardiovascular Diseases (CVDs) (World Health Organization). Available https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). Accessed 26 June 2019
Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A (2010) Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol 35:72–115
Karch AM (2012) Pharmacologial review: drugs that alter blood coagulation. Am Nurse Today 7:(11):26–31
Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G (2017) Global regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am College Cardiol 70(1):1–25
Aguirre J, Borgeat A (2013) Drugs for Thromboprophylaxis: unfractionated heparin, low molecular weight heparin, warfarin, and Fondaparinux. In: Llau JV (ed) Thromboembolism in orthopedic surgery, London: springer. England, London, pp 53–65
Bruno O, Schenone S, Ranise A, Bondavalli F, Barocelli E, Ballabeni V, Chiavarini M, Bertoni S, Tognolini M, Impicciatore M (2001) New polycyclic pyrimidine derivatives with antiplatelet in vitro activity: synthesis and pharmacological screening. Bioorg Med Chem 9:629–636
Izzo AA, Ernst E (2009) Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs 69(13):1777–1798
Ren J, Fu L, Nile SH, Zhang J, Kai G (2019) Salvia miltiorrhiza in treating cardiovascular diseases: a review on its pharmacological and clinical applications. Front Pharmacol 10:753
Tachjian A, Maria V, Jahangir A (2010) Use of herbal products and potential interactions in patients with cardiovascular diseases. J Am Coll Cardiol 55(6):515–525
Ao XL, Yu X, Wu DT, Li C, Zhang T, Liu SL, Chen SJ, He L, Zhou K, Zou LK (2018) Purification and characterization of neutral protease from Aspergillusoryzae Y1 isolated from naturally fermented broad beans. AMB Express 8(1):96
Frishman WH, Beravol P, Carosella C (2009) Alternative and complementary medicine for preventing and treating cardiovascular disease. Dis Mon 55(3):121–192
Lee W, Yang EJ, Ku SK, Song KS, Bae JS (2012) Anticoagulant activities of oleanolic acid via inhibition of tissue factor expressions. Kor Soc Biochem Mol Biol 45(7):390–395
Yeh GY, Davis RB, Phillips RS (2006) Use of complementary therapies in patients with cardiovascular disease. Am J Cardiol 98(5):673–680
Rawski RI, Sanecki PT, Dżugan M, Kijowska K (2018) The evidence of proteases in sprouted seeds and their application for animal protein digestion. Chem Zvesti 72(5):1213–1221
Martinez M, Gómez-Cabellos S, Giménez MJ, Barro F, Diaz I, Diaz-Mendoza M (2019) Plant proteases: from key enzymes in germination to allies for fighting human gluten-related disorders. Front Plant Sci 10:721
Urs AP, Rudresha GV, Manjuprasanna VN, Suvilesh KN, Gowda MDM, Yariswamy M, Hiremath V, Ramakrishnan C, Savitha MN, Jayachandra K, Sharanappa P, Vishwanath BS (2019) Plant latex thrombin-like cysteine proteases alleviates bleeding by bypassing factor VIII in murine model. J Cell Biochem 120(8):12843–12858
Kumar S, Joseph L, George M, Sharma A (2011) A review on anticoagulant/antithrombotic activity of natural plants used in traditional medicine. Int J Pharm Sci Rev Res 8:70–74
Newman DJ, Cragg GM (2012) Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 75:311–335
Otvos RA, Still KBM, Somsen GW, Smit AB, Kool J (2019) Drug discovery on natural products: from ion channels to nAChRs, from nature to libraries, from analytics to assays. SLAS Discov 24(3):362–385
Tabassum N, Ahmad F (2011) Role of natural herbs in the treatment of hypertension. Pharmacogn Rev 5(9):30–40
Cragg GM, Newman DJ (2013) Natural products: a continuing source of novel drug leads. Biochim Biophys Acta 1830(6):3670–3695
Francis AA, Deniset JF, Austria JA, LaValleé RK, Maddaford GG, Hedley TE, Dibrov E, Pierce GN (2013) Effects of dietary flaxseed on atherosclerotic plaque regression. Am J Physiol Heart Circ Physiol 304:1743–1751
Kim JH, Lee J, Kang S, Moon H, Chung KH, Kim KR (2016) Antiplatelet and antithrombotic effects of the extract of Linderaobtusiloba leaves. BiomolTher (Seoul) 24(6):659–664
Manicam C, Abdullah JO, Tohit ERM, Seman Z, Chin SC, Hamid M (2010) In vitro anticoagulant activities of Melastoma malabathricum Linn. aqueous leaf extract: a preliminary novel finding. J Med Plant Res 4(14):1464–1472
Dilara P, Mir Muhammad NU, Siddiqu MI, Salma P, Mohammad S (2013) Phytochemical screenings, thrombolytic activity and antimicrobial properties of the leaf extracts of lablab parpureus. Am J Res Com 1(2):49–55
Sheila MK, Anselimo OM, Glaston MK (2017) Physical characteristics, proximate composition and anti-nutritional factors in grains of lablab bean (Lablab purpureus) genotypes from Kenya. J App Bio 114:11289–11298
Kante K, Reddy CS (2013) Anti diabetic activity of Dolichos lablab (seeds) in streptozotocin-nicotinamide induced diabetic rats. Hyg J Dru Med 1:32–40
Maass BL, Knox MR, Venkatesha SC, Angessa TT, Ramme S, Pengelly BC (2010) Lablab purpureus – a crop lost for Africa. Tro Pla Bio 3(3):123–135
Shivashankar G, Kulkarni RS (1998) Lablab purpureus (L.) sweet. In: der Maesen LJG V, Somaatmadja S (eds) Plant resources of South-East Asia No 1. pulses. Pudoc, Wageningen, pp 48–50. Sheahan, CM. Plant guide for lablab (Lablab purpureus). USDA-Natural Resources Conservation Service, Cape May Plant Materials Center. Cap May. NJ. 2012
Thoyajakshi RS, Poornima D (2021) Anticoagulant, fibrinogenolytic and anti-platelet aggregation activities of lablab Purpureus (L.) sweet seed radicle aqueous extract. Plant Sci Today 8:89–94
Satake M, Murata Y, Suzuki T (1963) Studies on snake venoms XIII. Chromatographicseparation and properties of three proteinases from Agkistrodon halys blomhoffii venom. J Biochem 53:438–447
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
Shivaiah N, Kempaiah K (2011) ‘Partitagin’, a unique β, γ-fibrinogenase that inhibits platelet aggregation from Hippasa partita spider venom. Blood Coagul Fibrinolysis 22(1):24–28
Condrea E, Yang CC, Rosenberg P (1983) Anticoagulant activityand plasma phosphatidylserine hydrolysis by snake venomphospholipases A2. Thromb Haemost 49:151
Quick AJ, Stanley-Brown M, Bancroft FW (1935) A study of the coagulation defect in hemophilia and in jaundice. Am J Med Sci 190:501–511
Liu Y, Jennings NL, Dart AM, Du X-J (2012) Standardizing a simpler, more sensitive and accurate tail bleeding assay in mice. World J Exp Med 2(2):30
Lasukova T, Maslov L, Arbuzov A, Burkova V, Inisheva L (2015) Cardioprotective activity of Ganodermalucidum extract during total ischemia and reperfusion of isolated heart. Bull Exp Biol Med 158(6):739–741
Liperoti R, Vetrano DL, Bernabei R, Onder G (2017) Herbal medications in cardiovascular medicine. J Am College Cardiol 69(9):1188–1199
Kusuma CG, Gubbiveeranna V, Sumachirayu CK, Bhavana S, Ravikumar H, Nagaraju S (2020) The hemostatic activity of Manilkara zapota (L.) P. Royen latex associated with fibrinogenolytic activity. Plant Sci Today 7(3):469–475
Kusuma CG, Gubbiveeranna V, Sumachirayu CK, Bhavana S, Ravikumar H, Nagaraju S (2021) Thrombin- and plasmin-like and platelet-aggregation-inducing activities of Plumeria alba L. latex: action of cysteine protease. J Ethnopharmacol 273:114000
Ovanesov MV (2015) Study of the regulation of blood coagulation by factors VIIa and IXa. U.S food & drug aministration, biologic research project, New Hampshire Avenue, Silver Spring, MD
Nagaraju S, Girish KS, Fox JW, Kemparaju K (2007) “Partitagin” a hemorrhagicmetalloprotease from Hippasa partita spider venom: role in tissue necrosis. Biochimie 89(11):1322–1331
Nagaraju S, Mahadeswaraswamy YH, Girish KS, Kemparaju K (2006) Venom from spiders of the genus Hippasa: biochemical and pharmacological studies. Comp Biochem Physio 144(1):1–9
Poulsen BK, Grove EL, Husted SE (2012) New oral anticoagulants. Drugs 72:1739–1753
Yuan H, Ma Q, Ye L, Piao G (2016) The traditional medicine and modern medicine from natural products. Molecules 21(5):E559
El Haouari M, Mekhfi H (2017) Anti-platelet aggregation effects of extracts from Arbutus unedo leaves. Plant Sci 4(2):68–74
Félix-Silva J, Souzal T, Camara RBG, Cabral B, Silva-Júnior AA, Rebecchi IMM, Zucolotto SM, Rocha HAO, Fernandes-Pedrosa MF (2014) In vitro anticoagulant and antioxidant activities of Jatrophagossypiifolia L. (Euphorbiaceae) leaves aiming therapeutical applications. BMC Complement Altern Med 14:405
Vinod G, Kusuma CG, Bhavana S, Sumachirayu CK, Ravikumar H, Nagaraju S (2019) Potent procoagulant and platelet aggregation inducing serine protease from Tridax procumbens extract. Pharm Res 11(4):363–370
Vinod G, Kusuma CG, Bhavana S, Sumachirayu CK, Nagaraju S (2019a) Anti-hemostatic protease from Jatrophacurcas latex with fibrinogen lytic activity. J Pharmacogn Phytochem 8(1):1303–1310
Wang Z, Zhang J, Ren T, Dong Z (2016) Targeted metabolomic profiling of cardioprotective effect of Ginkgo biloba L. extract on myocardial ischemia in rats. Phytomedicine 23(6):621–631. https://doi.org/10.1016/j.phymed.2016.03.005
Gubbiveeranna V, Gangadharaiah KC, Thoyajakshi RS, Hemagirigowda R, Shivaiah N (2021) Anticoagulant and fibrinogenolytic properties of seed extract of psidium guajava. Indian J Pharm Sci 83(5):918–924
Valli G, Giardina EG (2002) Benefits, adverse effects and drug interactions of herbal therapies with cardiovascular effects. J Am Coll Cardiol 39(7):1083–1095
Mekhfi H, El Haouri M, Legssyer A, Bnouham M, Aziz M, Atmani F, Remmal A, Ziyyat A (2004) Platelet anti-aggregant property some Moroccan medicinal plants. J Ethnopharmacol 94:317–322
Vinod G, Nagaraju S (2016) Ethnomedicinal, phytochemical constituents and pharmacological activities of Tridax procumbens: a review. Int J Phar Pharm Sci 8(2):1–7
Liu Y, Oh SJ, Chang KH, Kim YG, Lee MY (2013) Antiplatelet effect of AMP-activated protein kinase activator and its potentiation by the phosphodiesterase inhibitor dipyridamole. Biochem Pharmacol 86(7):914–925
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Thoyajakshi, R.S., Nagaraju, S., Ravi Kumar, H., Poornima, D. (2023). Purification and Characterization of a Cysteine Protease from Sprouted Lablab purpureus Seed Radicle Extract: Its Effect on Blood Coagulation. In: Arunachalam, K., Yang, X., Puthanpura Sasidharan, S. (eds) Natural Product Experiments in Drug Discovery. Springer Protocols Handbooks. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2683-2_19
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2683-2_19
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2682-5
Online ISBN: 978-1-0716-2683-2
eBook Packages: Springer Protocols